SPAC Feed

VANCOUVER, British Columbia, Sept. 23, 2026 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today completed the previously announced acquisition of Theravance Biopharma. With the completion of the transaction, Theravance Biopharma is now part of Zymeworks, further advancing Zymeworks’ strategy to build a diversified revenue-generating biotechnology company, combining innovative R&D with growing commercial and royalty-based cash flows.

Zenta Group (Nasdaq: ZTG) clarifies 24,087,179 ordinary shares outstanding after its ZentoAI acquisition; some data platforms still show an older figure.

THIS PRESS RELEASE MAY NOT BE DISSEMINATED, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE ITS DISTRIBUTION, PUBLICATION OR DISSEMINATION WOULD BE ILLEGAL

CE COMMUNIQUÉ NE PEUT PAS ÊTRE DIFFUSÉ, DIRECTEMENT OU INDIRECTEMENT, DANS TOUTE JURIDICTION DANS LAQUELLE LA DISTRIBUTION, LA PUBLICATION OU LA DIFFUSION SERAIT ILLÉGALE

Following an inquiry brought by BBB National Programs’ National Advertising Division as part of its routine monitoring program, Syscend, Inc. d/b/a Guardian Bikes modified certain advertising claims and practices concerning its children’s and adult bicycles, including savings claims, strikethrough pricing, limited-time sale language, and consecutive countdown timers.

Following an inquiry brought by BBB National Programs’ National Advertising Division as part of its routine monitoring program, Syscend, Inc. d/b/a Guardian Bikes modified certain advertising claims and practices concerning its children’s and adult bicycles, including savings claims, strikethrough pricing, limited-time sale language, and consecutive countdown timers.

InstaMortgage reported approximately $4.5 million in revenue and $3.3 million in gross profit for the six months ended June 30, 2026, while reporting positive net income

Tower Semiconductor to Showcase Technology Innovation and Industry Leadership at its 2026 Technical Global Symposium in the United States

Tower Semiconductor to Showcase Technology Innovation and Industry Leadership at its 2026 Technical Global Symposium in the United States

Wednesday, September 23, 2026

FORM 8.3

Les agents IA quittent le rôle d’assistant pour devenir de vrais équipiers. La nouvelle plateforme d’Ibexa connecte les outils marketing, intègre les agents là où le travail se fait et prend en charge l’exécution des campagnes, du brief à la mise en ligne.

Garching / Munich, September 23, 2026 — ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Lumara Bio, a dedicated oncology therapeutics division of ITM, today announced that they will provide new data for Lu-edotreotide (ITM-11) in two poster presentations at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, held from September 26 – 30, 2026 in Boston, Massachusetts. One poster will feature Phase 3 COMPETE trial dosimetry results for ¹⁷⁷Lu-edotreotide in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs). A second poster will highlight findings from a registry analysis of re-treatment with ¹⁷⁷Lu-edotreotide in patients with progressive neuroendocrine tumors (NETs).

London, September 23, 2026 – Lift Therapeutics (‘Lift’ or ‘the Company’) today announced the appointment of Daniel Passeri, MSc, JD, as Chief Executive Officer (CEO). Mr. Passeri brings over 30 years of experience in oncology drug development, corporate strategy, and executive leadership, most recently serving as CEO of Cue Biopharma, where he led the company from inception into clinical development. Mr. Passeri succeeds Bo Rode Hansen, PhD, a member of Lift’s Board of Directors since 2023, who was appointed Interim CEO earlier this year during the search for a permanent CEO. Dr. Hansen will resume his role as a member of the Board of Directors and assume the role of President, where he will continue to leverage his deep corporate strategy and drug development experience to support the Company’s clinical development progress. LIfT Biosciences has been renamed Lift Therapeutics.

DUBAI, UAE, Sept. 23, 2026 (GLOBE NEWSWIRE) — Known Reputation, a reputation advisory serving founders, investors, political figures, and senior executives, has acquired Haut Monde Post, an independent Paris news media company.

SNS Insider Estimates, the Graphene Market is projected to reach USD 12,407.3 million by 2035, growing at a 30.0% CAGR, while the U.S. market is projected to reach USD 3,044.3 million, advancing at 29.5% CAGR, as advanced materials adoption expands across electronics, batteries, composites, and energy applications.

SNS Insider Estimates, the Graphene Market is projected to reach USD 12,407.3 million by 2035, growing at a 30.0% CAGR, while the U.S. market is projected to reach USD 3,044.3 million, advancing at 29.5% CAGR, as advanced materials adoption expands across electronics, batteries, composites, and energy applications.

We expect to release the Q3 2026 interim results of DSV A/S in the morning of 21 October 2026. A webcast and conference call will be held at 11:00 am CEST.      

Atos rejoint France Cyber Maritime pour accompagner la résilience cyber des acteurs maritimes, portuaires et fluviaux

Amsterdam – HERE Technologies, the world’s leading mapping and location data company, and NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO), a leading company in the global smart electric vehicle market, today announced an expanded collaboration to advance intelligent navigation and future AI-driven driving experiences across Europe.

Amsterdam – HERE Technologies, the world’s leading mapping and location data company, and NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO), a leading company in the global smart electric vehicle market, today announced an expanded collaboration to advance intelligent navigation and future AI-driven driving experiences across Europe.

阿姆斯特丹——全球领先的地图与位置数据公司HERE Technologies与全球智能电动汽车市场领军企业蔚来（NIO Inc.，NYSE: NIO；HKEX: 9866；SGX: NIO）今日宣布，双方将进一步扩大合作，共同推进欧洲智能导航与面向未来的AI驱动驾驶体验。